Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility Study

Kerstin Faravel, Marie-Eve Huteau, Marta Jarlier, Hélène de Forges, Laetitia Meignant, Pierre Senesse, Joanna Norton, William Jacot, Anne Stoebner, Kerstin Faravel, Marie-Eve Huteau, Marta Jarlier, Hélène de Forges, Laetitia Meignant, Pierre Senesse, Joanna Norton, William Jacot, Anne Stoebner

Abstract

Background: Osteo-articular pain (OAP) is experienced by approximately 50% of women under hormonal therapy (HT) for breast cancer (BC), which increases the risk for therapy discontinuation. This study was aimed to assess benefits of yoga practice combined with patient education (PE) for at-home practice by evaluating feasibility among BC patients under HT and measuring OAP, flexibility and satisfaction.

Methods: Feasibility was evaluated by patient adherence as accomplishment of at least 4 out of 6 supervised yoga-PE sessions along with 70% or more at-home yoga sessions. Intervention (12 weeks) included two 6-weeks periods: P1 comprising one 90-minutes supervised yoga-PE session/week and 15-minutes daily at-home yoga and P2, daily autonomous at-home yoga sessions. Evaluations (at inclusion and by the end of each period) consisted in assessment of OAP on Visual Analog Scale (VAS), forward flexibility (cm) and patient satisfaction on Likert (0-10 points) scale.

Results: Between September 2018 and May 2019 we included 24 patients of median 53 years (range 36-72). Feasibility was validated by 83% successful adherence rate. Pain was significantly reduced from median VAS of 6 [range 4-10] to 4 [range 0-7] at the end of both P1 and P2 (p < 0.01), albeit with no difference between P1 and P2. Forward flexibility improved by a median gain of 8 cm (end of P2) and median satisfaction score of 10/10 [range 8-10].

Conclusion: Combined physiotherapy-yoga-PE intervention is a feasible strategy to increase at-home yoga practice with potential benefit on pain, flexibility, and satisfaction, thus prompting further evaluations in larger randomized multicenter trials.

Clinicaltrials.gov: NCT04001751.

Keywords: breast cancer; hormonal therapy; pain; patient education; physiotherapy; yoga.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flow diagram of participant recruitment and main steps in the intervention.
Figure 2.
Figure 2.
Osteo articular pain and flexibility values by visit.

References

    1. Burstein HJ. Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer. N Engl J Med. 2020;383:2557-2570.
    1. Burstein HJ, Lacchetti C, Anderson H, et al.. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37:423-438.
    1. Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26:556-562.
    1. Oberguggenberger A, Hubalek M, Sztankay M, et al.. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Res Treat. 2011;128:553-561.
    1. Chim K, Xie SX, Stricker CT, et al.. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors. BMC Cancer. 2013;13:401.
    1. Group (EBCTCG) EBCTC. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet. 2011;378:771-784.
    1. Niravath P. Aromatase inhibitor-induced arthralgia: a review. Ann Oncol. 2013;24:1443-1449.
    1. Pistilli B, Paci A, Ferreira AR, et al.. Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk. J Clin Oncol. 2020;38:2762-2772.
    1. Berkowitz MJ, Thompson CK, Zibecchi LT, et al.. How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support. J Cancer Surviv. 2021;15:29-39.
    1. Crew KD, Greenlee H, Capodice J, et al.. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol. 2007;25:3877-3883.
    1. Lintermans A, Van Asten K, Wildiers H, et al.. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI. Breast Cancer Res Treat. 2014;146:109-116.
    1. Qian X, Li Z, Ruan G, Tu C, Ding W. Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials. Breast Cancer Res Treat. 2020;179:275-285.
    1. Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al.. Clinical practice guidelines on the evidence-based use of integrative therapies during and following breast cancer treatment. CA Cancer J Clin. 2017;67:194-232.
    1. Lyman GH, Greenlee H, Bohlke K, et al.. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36:2647-2655.
    1. Gupta A, Henry NL, Loprinzi CL. Management of aromatase inhibitor-induced musculoskeletal symptoms. J Oncol Pract. 2020;16:733-739.
    1. Lombard JM, Zdenkowski N, Wells K, et al.. Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options. Support Care Cancer. 2016;24:2139-2146.
    1. Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev. 2017;1:CD010802.
    1. Kiecolt-Glaser JK, Bennett JM, Andridge R, et al.. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32:1040-1049.
    1. Chandwani KD, Perkins G, Nagendra HR, et al.. Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapy. J Clin Oncol. 2014;32:1058-1065.
    1. Bower JE, Garet D, Sternlieb B, et al.. Yoga for persistent fatigue in breast cancer survivors: a randomized controlled trial. Cancer. 2012;118:3766-3775.
    1. Rao RM, Vadiraja HS, Nagaratna R, et al.. Effect of yoga on sleep quality and neuroendocrine immune response in metastatic breast cancer patients. Indian J Palliat Care. 2017;23:253-260.
    1. Komatsu H, Yagasaki K, Yamauchi H, Yamauchi T, Takebayashi T. A self-directed home yoga programme for women with breast cancer during chemotherapy: a feasibility study: yoga for patients undergoing chemotherapy. Int J Nurs Pract. 2016;22:258-266.
    1. Galantino ML, Desai K, Greene L, Demichele A, Stricker CT, Mao JJ. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias. Integr Cancer Ther. 2012;11:313-320.
    1. Peppone LJ, Janelsins MC, Kamen C, et al.. The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Res Treat. 2015;150:597-604.
    1. Jacobsen PB, Muchnick S, Marcus S, et al.. Pilot study of Iyengar yoga for management of aromatase inhibitor-associated arthralgia in women with breast cancer. Psychooncology. 2015;24:1578-1580.
    1. Cramer H, Rabsilber S, Lauche R, Kümmel S, Dobos G. Yoga and meditation for menopausal symptoms in breast cancer Survivors: a randomized controlled trial. Cancer. 2015;121:2175-2184.
    1. Bonnabel L, Huteau M-È, Filhol N, et al.. [Combining clinical pathway and patient education approaches]. Rev Infirm. 2016;65: 38-40.
    1. Haute Autorité de Santé. Structuration d’un programme d’éducation thérapeutique du patient dans le champ des maladies chroniques; 2007. Accessed April 24, 2019.
    1. Howell D, Harth T, Brown J, Bennett C, Boyko S. Self-management education interventions for patients with cancer: a systematic review. Support Care Cancer. 2017;25:1323-1355.
    1. Gollwitzer PM. Weakness of the will: is a quick fix possible? Motiv Emot. 2014;38:305-322.
    1. Hagger MS, Luszczynska A. Implementation intention and action planning interventions in health contexts: state of the research and proposals for the way forward. Appl Psychol Health Well Being. 2014;6:1-47.
    1. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179-211.
    1. Machin D, Campbell M, Tan S, et al.. Sample Size Tables for Clinical Studies. 3rd ed. Wiley-Blackwell; 2011.
    1. Baydoun M, Barton DL, Peterson M, et al.. Yoga for cancer-related fatigue in survivors of hematopoietic cell transplantation: a feasibility study. J Pain Symptom Manag. 2020;59:702-708.
    1. Danhauer SC, Addington EL, Cohen L, et al.. Yoga for symptom management in oncology: a review of the evidence base and future directions for research. Cancer. 2019;125:1979-1989.
    1. Institut National du Cancer. La vie cinq ans après un diagnostic de cancer. Institut National du Cancer; 2018:364.
    1. Wieber F, Thürmer JL, Gollwitzer PM. Promoting the translation of intentions into action by implementation intentions: behavioral effects and physiological correlates. Front Hum Neurosci. 2015;9:9. .
    1. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4:2-21.
    1. Andersson V, Bergman S, Henoch I, Simonsson H, Ahlberg K. Benefits of using the brief pain inventory in patients with cancer pain: an intervention study conducted in Swedish hospitals. Support Care Cancer. 2020;28:3721-3729.
    1. Galantino ML, Greene L, Archetto B, et al.. A qualitative exploration of the impact of yoga on breast cancer survivors with aromatase inhibitor-associated arthralgias. Explore. 2012;8:40-47.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel